Author: Zacks Small Cap Research

1565758596071580 / 710 POSTS
By Lisa ThompsonNASDAQ:RVLTRevolution Lighting Technologies (NASDAQ:RVLT) returned to revenue growth by reporting Q1 revenues of $33.7 million versus $30.6 million a year ago, up 10%. While some sales did slip from Q4 into Q1, restructuring right siz ...
By David Bautz, PhDNASDAQ:MNOVMediciNova, Inc. (NASDAQ:MNOV) recently had additional data presented on one of its lead compounds, MN-166 (ibudilast), in two different indications at the American Academy of Neurology (AAN) 70th Annual Meeting. Progres ...
By David Bautz, PhDNASDAQ:MTPBusiness UpdateMidatech Pharma Plc (NASDAQ:MTP) is a specialty pharmaceutical company with three novel drug delivery technologies. The technologies are designed to enable the targeted delivery, sustained release, or solub ...
By David Bautz, PhDNASDAQ:MTFBBusiness UpdateMotif Bio Plc (NASDAQ:MTFB) is a biopharmaceutical company focused on the development of antibiotic compounds for difficult to treat bacterial infections. The company’s lead asset, iclaprim, is a novel dia ...
By Steven Ralston, CFAOTC:MEECSUMMARY2017 Achievements:• As demand for electricity from coal-fired EGUs seasonally increases during the warmer months, Midwest Energy Emissions (OTC:MEEC) operates profitably during the 2nd and 3rd quarters. The coal-f ...
By Steven Ralston, CFATSX:WML.VExecutive Summary• Wealth Minerals (TSX:WML.V) announced that the company had entered into an agreement with ENAMI to form a strategic alliance     ◦ Management anticipates that it will be 24-month process to formally f ...
By John Vandermosten, CFATSX:RVX.VResverlogix Closes FinancingOn April 11, 2018, Resverlogix Corp. (TSX:RVX.V) announced the closing of $3.2 million in equity financing and accepted a commitment letter for a US$30 million loan. The equity financing w ...
By John Vandermosten, CFATSX:RVXResverlogix Closes FinancingOn April 11, 2018, Resverlogix Corp. (TSX:RVX) announced the closing of $3.2 million in equity financing and accepted a commitment letter for a US$30 million loan. The equity financing was a ...
By John Vandermosten, CFATSX:RVXResverlogix Closes FinancingOn April 11, 2018, Resverlogix Corp. (TSX:RVX) announced the closing of $3.2 million in equity financing and accepted a commitment letter for a US$30 million loan. The equity financing was a ...
By John Vandermosten, CFANASDAQ:TENXLevosimendan is a calcium sensitizer and K-ATP channel activator that can improve systolic and diastolic function of the heart as well as provide vasodilatory effects through its ability to relax vascular smooth mu ...
1565758596071580 / 710 POSTS